Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol for Gastroparesis (HATGAS)
NCT02057549Phase 4Terminated
- Sponsor
- UTHealth Houston
- Start
- Nov 2012
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of haloperidol in gastroparesis, sponsored by UTHealth Houston. Started Nov 2012; status: terminated.
02
Drugs
haloperidol
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT02057549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057549.